CHE Stock Falls Despite Q1 Earnings & Revenue Beat, Gross Margin Declines
Chemed delivers first-quarter top-line growth across two of its segments, VITAS and Roto-Rooter.
Chemed Corporation (CHE) Q1 2025 Earnings Call Transcript
Chemed Corporation (NYSE:CHE ) Q1 2025 Earnings Conference Call April 24, 2025 10:00 AM ET Company Participants Holley Schmidt - Assistant Controller Kevin McNamara - President and CEO Mike Witzeman - CFO Nick Westfall - Chairman and CEO, Chemed VITAS Healthcare Corporation Conference Call Participants Ben Hendrix - RBC Capital Markets Operator Good day, and thank you for standing by. Welcome to the Chemed Corporation First Quarter 2025 Earnings Conference Call.
Chemed (CHE) Surpasses Q1 Earnings and Revenue Estimates
Chemed (CHE) came out with quarterly earnings of $5.63 per share, beating the Zacks Consensus Estimate of $5.60 per share. This compares to earnings of $5.20 per share a year ago.
Why Is Chemed (CHE) Up 4.5% Since Last Earnings Report?
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
Chemed Q4 Earnings & Revenues Top, Stock Climbs, Margins Contract
CHE's earnings and revenues beat estimates in the fourth quarter of 2024.
Chemed Corporation (CHE) Q4 2024 Earnings Call Transcript
Chemed Corporation (NYSE:CHE ) Q4 2024 Earnings Conference Call February 27, 2025 10:00 AM ET Company Participants Holley Schmidt – Assistant Controller Kevin McNamara – President and Chief Executive Officer Mike Witzeman – Chief Financial Officer Nick Westfall – Chairman and Chief Executive Officer, Chemed VITAS Healthcare Corporation Conference Call Participants Michael Murray – RBC Capital Markets Christian Porter – Bank of America Operator Hello, and welcome to the Chemed Corporation Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Chemed (CHE) Surpasses Q4 Earnings and Revenue Estimates
Chemed (CHE) came out with quarterly earnings of $6.83 per share, beating the Zacks Consensus Estimate of $6.79 per share. This compares to earnings of $6.60 per share a year ago.
Should Investors Hold Chemed Stock in Their Portfolio Now?
CHE stays on investors' radar due to its robust prospects in the VITAS business and the resilient Roto-Rooter arm.
Chemed Stock Hurt by Roto-Rooter Softness, Macro Issues Dent Growth
The ongoing global economic conditions, such as general labor, supply chain and inflationary pressure, along with political and regulatory developments, are escalating expenses for CHE.
Chemed Corporation (CHE) Q3 2024 Earnings Call Transcript
Chemed Corporation (NYSE:CHE ) Q3 2024 Earnings Conference Call October 30, 2024 10:00 AM ET Company Participants Holley Schmidt - Assistant Controller Kevin McNamara - President and Chief Executive Officer Mike Witzeman - Chief Financial Officer Nick Westfall - Chairman and Chief Executive Officer, VITAS Healthcare Corporation Conference Call Participants Ben Hendrix - RBC Capital Markets Joanna Gajuk - Bank of America Operator Good day and thank you for standing by. Welcome to the Chemed Corporation Third Quarter 2024 Earnings Conference Call.
CHE Misses on Q3 Earnings, Lowers '24 EPS View, Stock Up
Chemed's VITAS segment reports impressive revenue growth and margin expansion for the third quarter of 2024.
Chemed (CHE) Lags Q3 Earnings and Revenue Estimates
Chemed (CHE) came out with quarterly earnings of $5.64 per share, missing the Zacks Consensus Estimate of $5.76 per share. This compares to earnings of $5.32 per share a year ago.
